Published in Nat Rev Neurol on September 12, 2016
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Management of sepsis. N Engl J Med (2006) 9.01
Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 7.95
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA (2004) 6.38
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation (2001) 5.49
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke (2001) 4.87
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 4.52
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med (2005) 4.13
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J (2011) 3.93
Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med (2012) 3.88
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr (2004) 3.61
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med (2003) 3.49
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest (2004) 3.23
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation (2003) 3.15
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00
Global burden of intracranial atherosclerosis. Int J Stroke (2006) 2.98
Beneficial cardiovascular pleiotropic effects of statins. Circulation (2004) 2.89
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology (2011) 2.71
Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70
Acute infection contributes to racial disparities in stroke mortality. Neurology (2014) 2.70
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation (2006) 2.69
The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure (1999) 2.64
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation (2005) 2.48
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood (1993) 2.48
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation (2002) 2.45
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA (2014) 2.39
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA (2010) 2.30
Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology (2002) 2.11
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J Thromb Haemost (2009) 2.08
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther (2010) 2.01
Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res (2009) 1.95
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA (2002) 1.95
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation (2003) 1.93
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81
The origins of vertebrate adaptive immunity. Nat Rev Immunol (2010) 1.81
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med (2006) 1.73
Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA (2005) 1.70
C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler Thromb Vasc Biol (2008) 1.66
Exercise and risk of stroke in male physicians. Stroke (1999) 1.65
Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation (2005) 1.64
How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost (2009) 1.63
Coagulation and innate immune responses: can we view them separately? Blood (2009) 1.61
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care (2002) 1.59
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J (2013) 1.53
AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev (2011) 1.53
A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med (2000) 1.52
Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev (2015) 1.50
Leukocyte count as an independent predictor of recurrent ischemic events. Stroke (2004) 1.50
Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov (2011) 1.48
Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48
Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation. Clin Chem (2011) 1.46
Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology (2015) 1.45
C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation (2003) 1.32
Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr (2007) 1.32
Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation (2005) 1.32
Vascular inflammation in cerebral small vessel disease. Neurobiol Aging (2011) 1.32
Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32
Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation (2002) 1.28
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res (2012) 1.28
Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology (2012) 1.28
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28
CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges. Pharmacol Rev (2013) 1.27
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol (2004) 1.25
Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr (2004) 1.24
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J (2006) 1.22
Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke (2005) 1.20
Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke (2011) 1.18
Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke (2008) 1.17
The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol (2002) 1.14
Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol (2010) 1.13